Uncategorized

2202-60190

Quality-assured mifepristone as emergency contraception: A next generation option for an existing abortion pill

  Concept Foundation    Argentina, Ethiopia, Ghana, Netherlands, Sweden, Tanzania, Thailand, and Switzerland

Concept Foundation seeks to expand the regulatory pathway of mifepristone an as emergency contraceptive in low- and middle-income countries, exploring pathways to bring mifepristone as a quality-assured, low-cost, over the counter emergency contraceptive to market. Concept Foundation will prepare a data package to demonstrate mifepristone can be registered using existing evidence, supported by an advisory committee. Once the data package is finalized, Concept Foundation will meet with regulatory authorities and agencies to establish pathways to register mifepristone as a quality-assured emergency contraceptive product.

Uncategorized

2203-60219

The investment case for a novel letrozole-misoprostol medical abortion combipack

  Concept Foundation     Switzerland

Concept Foundation aims to demonstrate if a quality assured letrozole and misoprostol regimen for MA will serve as an affordable alternative treatment to the existing MA regimens and will increase access to safe medical abortion in low- and middle-income country markets. Concept Foundation will establish an investment case, providing information for decision making towards product development for letrozole as an abortifacient with misoprostol.